Dimensional Fund Advisors LP Neogenomics Inc Transaction History

Dimensional Fund Advisors LP

$418 Billion
Q2 2025

A detailed history of Dimensional Fund Advisors LP transactions in Neogenomics Inc stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 4,293,657 shares of NEO stock, worth $39.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,293,657

Previous 3,845,129 11.66%

Holding current value

$39.1 Million

Previous $36.5 Million 13.99%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$6.4 - $10.27 $2.87 Million - $4.61 Million	448,528 Added 11.66%	4,293,657 $31.4 Million
Q1 2025 May 13, 2025	BUY	$9.09 - $18.61 $3.71 Million - $7.6 Million	408,271 Added 11.88%	3,845,129 $36.5 Million
Q4 2024 Feb 13, 2025	BUY	$13.0 - $18.43 $1.02 Million - $1.44 Million	78,211 Added 2.33%	3,436,858 $56.6 Million
Q3 2024 Nov 07, 2024	BUY	$13.4 - $17.73 $455,908 - $603,227	34,023 Added 1.02%	3,358,647 $49.5 Million
Q2 2024 Aug 09, 2024	BUY	$13.01 - $15.77 $2.83 Million - $3.43 Million	217,687 Added 7.01%	3,324,624 $46.1 Million
Q1 2024 May 10, 2024	BUY	$14.06 - $16.79 $1.41 Million - $1.69 Million	100,414 Added 3.34%	3,106,937 $48.8 Million
Q4 2023 Feb 07, 2024	BUY	$11.67 - $20.73 $217,097 - $385,640	18,603 Added 0.62%	3,006,523 $48.6 Million
Q3 2023 Nov 09, 2023	BUY	$12.15 - $17.85 $91,683 - $134,696	7,546 Added 0.25%	2,987,920 $36.8 Million
Q2 2023 Aug 09, 2023	BUY	$14.1 - $19.83 $4.06 Million - $5.71 Million	287,767 Added 10.69%	2,980,374 $47.9 Million
Q1 2023 May 12, 2023	BUY	$9.09 - $19.45 $8.2 Million - $17.5 Million	902,024 Added 50.38%	2,692,607 $46.9 Million
Q4 2022 Feb 09, 2023	BUY	$6.45 - $12.07 $5.27 Million - $9.86 Million	816,712 Added 83.86%	1,790,583 $16.5 Million
Q3 2022 Nov 10, 2022	SELL	$7.86 - $12.91 $1.97 Million - $3.23 Million	-250,303 Reduced 20.45%	973,871 $8.39 Million
Q2 2022 Aug 12, 2022	SELL	$7.06 - $13.97 $1.35 Million - $2.68 Million	-191,804 Reduced 13.55%	1,224,174 $9.98 Million
Q1 2022 May 13, 2022	SELL	$12.15 - $35.28 $1.46 Million - $4.23 Million	-119,878 Reduced 7.81%	1,415,978 $17.2 Million
Q4 2021 Feb 09, 2022	BUY	$30.49 - $48.49 $4.72 Million - $7.5 Million	154,691 Added 11.2%	1,535,856 $52.4 Million
Q3 2021 Nov 12, 2021	BUY	$41.66 - $52.52 $13.1 Million - $16.5 Million	314,094 Added 29.44%	1,381,165 $66.6 Million
Q2 2021 Aug 12, 2021	BUY	$36.62 - $51.69 $5.37 Million - $7.59 Million	146,755 Added 15.95%	1,067,071 $48.2 Million
Q1 2021 May 14, 2021	SELL	$41.56 - $59.88 $11.4 Million - $16.4 Million	-273,883 Reduced 22.93%	920,316 $44.4 Million
Q4 2020 Feb 25, 2021	BUY	$36.08 - $56.47 $43.1 Million - $67.4 Million	1,194,199 New	1,194,199 $64.3 Million

Others Institutions Holding NEO

# of Institutions

307

Shares Held

129M

Call Options Held

1.17M

Put Options Held

297K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.14B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Neogenomics Inc Transaction History